Page last updated: 2024-11-06

mitomycin and Pleurisy

mitomycin has been researched along with Pleurisy in 5 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Pleurisy: INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.

Research Excerpts

ExcerptRelevanceReference
"A new drug dosage form comprising activated carbon particles adsorbing mitomycin C (MMC-CH) is designed to slowly release its components, and has affinity for the tumor surface and lymph nodes and a tendency to stay long in the local portion."6.66Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials. ( Hagiwara, A; Itoh, T; Lee, R; Takahashi, T; Takeda, M; Ueda, T, 1987)
"Fourteen cases of adenocarcinoma with pleuritis carcinomatosa (lung cancer 10 cases, ovarian cancer 2 cases, colon cancer 2 cases) were treated with intra-pleural instillation of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083), a derivative of mitomycin C."3.67[Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa]. ( Eguchi, K; Garcia-Herreros, P; Hoshi, A; Nomori, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K, 1984)
"A new drug dosage form comprising activated carbon particles adsorbing mitomycin C (MMC-CH) is designed to slowly release its components, and has affinity for the tumor surface and lymph nodes and a tendency to stay long in the local portion."2.66Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials. ( Hagiwara, A; Itoh, T; Lee, R; Takahashi, T; Takeda, M; Ueda, T, 1987)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Urata, A1
Nishimura, M1
Ota, K1
Shimizu, E1
Saijo, N1
Shinkai, T1
Eguchi, K1
Tominaga, K1
Nomori, H1
Sasaki, Y1
Garcia-Herreros, P1
Hoshi, A1
Yokota, T1
Hagiwara, A2
Sawai, K1
Yamaguchi, T1
Shimotsuma, M1
Sasabe, T1
Ohyama, T1
Takahashi, T2
Lee, R1
Ueda, T1
Takeda, M1
Itoh, T1
Hattori, H1
Mikuriya, S1
Mamiya, T1
Hatano, K1
Shiina, T1
Yamada, T1

Trials

2 trials available for mitomycin and Pleurisy

ArticleYear
[Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:6

    Topics: Adult; Aged; Biological Products; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Mi

1983
Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials.
    Cancer, 1987, Jan-15, Volume: 59, Issue:2

    Topics: Charcoal; Clinical Trials as Topic; Dosage Forms; Female; Humans; Microscopy, Electron; Middle Aged;

1987

Other Studies

3 other studies available for mitomycin and Pleurisy

ArticleYear
[Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Colonic Neoplasms; Female; Fever; Huma

1984
Mitomycin C adsorbed on activated carbon particles: is intraperitoneal chemotherapy effective for synchronous pleuritis carcinomatosa?
    The American journal of gastroenterology, 1989, Volume: 84, Issue:9

    Topics: Adult; Female; Humans; Injections, Intraperitoneal; Krukenberg Tumor; Mitomycin; Mitomycins; Ovarian

1989
[Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Gan no rinsho. Japan journal of cancer clinics, 1988, Volume: 34, Issue:7

    Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; D

1988